BIO’s Crowley explains position on Biosecure Act, efforts to ease impacts

BIO’s John Crowley believes that biotechnology is part of a “great global rivalry” between the U.S. and China. “What we’re talking about is defending broad principles and a broad way of life, and showcasing what free and democratic societies, free-enterprise-based systems, can produce.”

The role of biotechnology in determining the outcome of this rivalry, and a belief in the need to reduce U.S. reliance on Chinese biotech companies, led BIO to reverse its opposition to the Biosecure Act, and to ask WuXi AppTec Co. Ltd. (Shanghai:603259; HKEX:2359) to withdraw from the trade association, the president and CEO of BIO said in an interview with The BioCentury Show. ...